Literature DB >> 3300233

New perspectives on cardiovascular risk factors.

W B Kannel.   

Abstract

Atherogenic traits, living habits, signs of preclinical disease, and susceptibility all contribute to cardiovascular disease. High low-density lipoprotein is positively related to coronary heart disease, and high high-density lipoprotein is inversely related. Systolic or diastolic hypertension at any age in either sex contributes powerfully. The impact of diabetes is greater for women and varies with the number of accompanying risk factors. High-normal fibrinogen values further escalate risk of these atherogenic factors. An atherogenic life-style is typified by a diet excessive in fat, calories, and salt; sedentary habits; unrestrained weight gain; and cigarette smoking. Moderate alcohol use may be beneficial. Use of oral contraceptives beyond age 35 years and in conjunction with cigarette smoking predisposes one to thromboembolism. Type A behavior carries an increased risk, and men married to more highly educated women and to women in white-collar jobs are more vulnerable. Signs of preclinical ischemia include silent myocardial infarction, left ventricular hypertrophy on ECG, blocked intraventricular conduction, and repolarization abnormalities. Measures of innate susceptibility include a family history of early cardiovascular disease. Quantitative combination of risk factors provides optimal prediction, including persons with multiple marginal abnormalities. Preventive management should also be multifactorial and requires a commitment to behavior modification and alteration in life-style.

Entities:  

Mesh:

Year:  1987        PMID: 3300233     DOI: 10.1016/0002-8703(87)90964-1

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Marital differences in blood pressure and the risk of hypertension among Polish men.

Authors:  Anna Lipowicz; Monika Lopuszanska
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation.

Authors:  F Tanriverdi; Z Karaca; K Unluhizarci; F Kelestimur
Journal:  Endocrine       Date:  2014-05-11       Impact factor: 3.633

3.  Effects of Cysteine-Stabilised Peptide Fraction of Aqueous Extract of Morinda lucida Leaf on Selected Cardiovascular Disease Indices in Mice.

Authors:  Kayode Ezekiel Adewole; Adedoyin Igunnu; Joseph Oluwatope Adebayo
Journal:  Indian J Clin Biochem       Date:  2018-07-17

4.  Plasma and erythrocyte manganese concentrations. Influence of age and acute myocardial infarction.

Authors:  J Arnaud; P Bourlard; B Denis; A E Favier
Journal:  Biol Trace Elem Res       Date:  1996       Impact factor: 3.738

Review 5.  Extreme Atherosclerotic Cardiovascular Disease (ASCVD) Risk Recognition.

Authors:  Paul D Rosenblit
Journal:  Curr Diab Rep       Date:  2019-07-22       Impact factor: 4.810

6.  Prevalence of cardiovascular disease risk factors in a southwestern Native American tribe.

Authors:  D Campos-Outcalt; J Ellis; M Aickin; J Valencia; M Wunsch; L Steele
Journal:  Public Health Rep       Date:  1995 Nov-Dec       Impact factor: 2.792

7.  Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology.

Authors:  Connie W Tsao; Ramachandran S Vasan
Journal:  Int J Epidemiol       Date:  2015-12       Impact factor: 7.196

Review 8.  Sudden cardiac death and the potential role of beta-adrenoceptor-blocking drugs.

Authors:  I Rajman; M J Kendall
Journal:  Postgrad Med J       Date:  1993-12       Impact factor: 2.401

Review 9.  Oxidized low density lipoprotein, stem cells, and atherosclerosis.

Authors:  Hui Yang; Ahmed Salah Salem Mohamed; Sheng-Hua Zhou
Journal:  Lipids Health Dis       Date:  2012-07-02       Impact factor: 3.876

Review 10.  Chronotropic incompetence: causes, consequences, and management.

Authors:  Peter H Brubaker; Dalane W Kitzman
Journal:  Circulation       Date:  2011-03-08       Impact factor: 39.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.